Julia Woźna, Jan Stępka, Andrzej Bałoniak, Ryszard Żaba
{"title":"Teledermatology in the diagnosis and treatment of sexually transmitted infections: a narrative review.","authors":"Julia Woźna, Jan Stępka, Andrzej Bałoniak, Ryszard Żaba","doi":"10.5114/ada.2023.135615","DOIUrl":"10.5114/ada.2023.135615","url":null,"abstract":"<p><p>Teledermatology is a dynamically developing field of medicine with the potential to significantly impact the future functioning of the healthcare system, including the prevention, diagnostics, and treatment of sexually transmitted infections (STIs). While its implementation has resolved numerous issues associated with the traditional patient management model for STIs, the risk associated with handling sensitive patient data in a virtual space must not be overlooked. This article presents a literature review regarding the application of teledermatology in the diagnostics and treatment of STIs, with a particular focus on addressing relevant problems, potential obstacles, and examining the impact of the COVID-19 global epidemic on the development of this field.</p>","PeriodicalId":54595,"journal":{"name":"Postepy Dermatologii I Alergologii","volume":"41 1","pages":"1-8"},"PeriodicalIF":1.4,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10962372/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140295786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ana Popovic, Milica Djurovic Bojic, Milos Bojic, Filip Vukmirovic, Aleksandar Juskovic
{"title":"Cutaneous metastases of cervical cancer: a rare entity and possible mechanisms of dissemination.","authors":"Ana Popovic, Milica Djurovic Bojic, Milos Bojic, Filip Vukmirovic, Aleksandar Juskovic","doi":"10.5114/ada.2023.135603","DOIUrl":"10.5114/ada.2023.135603","url":null,"abstract":"","PeriodicalId":54595,"journal":{"name":"Postepy Dermatologii I Alergologii","volume":"41 1","pages":"136-138"},"PeriodicalIF":1.4,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10962380/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140295355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Aryl hydrocarbon receptor role in chronic inflammatory skin diseases: a narrative review.","authors":"Michał Dec, Hubert Arasiewicz","doi":"10.5114/ada.2023.135617","DOIUrl":"10.5114/ada.2023.135617","url":null,"abstract":"<p><p>The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that has gained increasing attention in the field of dermatology due to its multifaceted role in skin health and disease. This review provides a comprehensive overview of the current state of knowledge regarding the AHR and its implications in dermatological conditions. The AHR is well known for its involvement in xenobiotic metabolism, particularly in response to polycyclic aromatic hydrocarbons and dioxins. However, recent research has unveiled its pivotal role in the skin immune response, barrier function, and homeostasis. The AHR signalling pathway is intricately linked to various dermatological disorders, including psoriasis, atopic dermatitis, acne and hidradenitis suppurativa. In this review, we delve into the molecular mechanisms through which AHR activation influences skin physiology and highlight how dysregulation can lead to pathological conditions. Moreover, we discuss the emerging therapeutic potential of AHR modulators in the treatment of skin diseases. In conclusion, the AHR is a pivotal player in dermatology, with a multifaceted role in skin physiology and pathology. Understanding the intricacies of AHR signalling in the skin offers promising avenues for the development of novel therapies and preventive strategies for various dermatological conditions. Further research is warranted to elucidate the full scope of AHR's contributions to dermatology and its potential as a therapeutic target.</p>","PeriodicalId":54595,"journal":{"name":"Postepy Dermatologii I Alergologii","volume":"41 1","pages":"9-19"},"PeriodicalIF":1.4,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10962376/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140295348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Weijing Fan, Huimin Lu, Xin Yuan, Kun Zhao, Guobin Liu
{"title":"Effect of total astragalosides on diabetic non-healing wound by regulating immune microenvironment.","authors":"Weijing Fan, Huimin Lu, Xin Yuan, Kun Zhao, Guobin Liu","doi":"10.5114/ada.2024.135989","DOIUrl":"10.5114/ada.2024.135989","url":null,"abstract":"<p><strong>Aim: </strong>The aim of the research was to analyse the regulatory effect of astragaloside (AST) on the immune microenvironment of diabetic non-healing wound (DNHW), and to analyse the clinical efficacy and mechanism of wound repair in multiple layers.</p><p><strong>Material and methods: </strong>Ninety adult male Wistar rats, which were kept healthy (SPF) under natural infection, were randomly divided into three groups, namely, blank, control and observation groups, with 30 rats in each group. After adaptive feeding for 7 days, the diabetes model was established. After the model was formed, the wounds were uniformly prepared, and then the blank group only was shaved. Both the control group and the observation group were treated with moist exposure therapy. The control group was covered with physiological saline gauze, while the observation group was covered with AST gauze. The healing status of the wounds in both groups was observed and recorded on the 1<sup>st</sup>, 7<sup>th</sup>, and 14<sup>th</sup> days after formation. And the levels of α-smooth muscle actin (α-SMA) and collagen I (COL-1) in the wound tissue were measured.</p><p><strong>Results: </strong>On the 1st day after wound formation, the wound healing area, α-SMA, and COL-1 levels in the three groups were consistent (<i>p</i> > 0.05). On the 7<sup>th</sup> and 14<sup>th</sup> days after wound formation, the wound healing area in the three groups increased compared within the group, but only the control and observation groups had significantly higher wound healing area than on the 1st day after wound formation (<i>p</i> < 0.05). In addition, the blank group had lower levels of α-SMA and COL-1, while the control and observation groups had higher levels of α-SMA and COL-1 (<i>p</i> < 0.05). In the comparison between groups, the wound healing area, α-SMA, and COL-1 levels in the control and observation groups were higher than those in the blank group, while the wound healing area, α-SMA, and COL-1 levels in the observation group were higher than those in the control group (<i>p</i> < 0.05).</p><p><strong>Conclusions: </strong>AST can regulate the immune microenvironment of DNHW, improve α-SMA and COL-1, and accelerate the wound healing of DNHW.</p>","PeriodicalId":54595,"journal":{"name":"Postepy Dermatologii I Alergologii","volume":"41 1","pages":"100-105"},"PeriodicalIF":1.4,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10962366/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140295357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Vacuum sealing drainage technique combined with carbon nanomaterial dressings applied in the treatment of skin wounds.","authors":"Yan Li, Guiqiu Dong, Yun Xie, Jie Wang","doi":"10.5114/ada.2024.136036","DOIUrl":"10.5114/ada.2024.136036","url":null,"abstract":"<p><strong>Introduction: </strong>Limb trauma (LT) encompasses a variety of conditions and currently poses certain therapeutic challenges in clinical practice.</p><p><strong>Aim: </strong>To assess the effectiveness of applying the vacuum sealing drainage (VSD) technique combined with carbon nanomaterial (CNM) dressings in the nursing treatment of LT patients.</p><p><strong>Material and methods: </strong>Eighty-six LT patients were enrolled into a control (Ctrl) group and an experimental (Exp) group. Patients in the Ctrl group underwent conventional wound cleansing and drainage methods with regular dressings, while those in the Exp group received VSD combined with CNM dressings. Both groups received the same nursing procedures. Various indicators were observed and compared to analyse the final outcomes.</p><p><strong>Results: </strong>The Exp group exhibited a higher favourable wound healing (FWH) rate, overall limb functional recovery (LFR) rate, and nursing satisfaction compared to the Ctrl group (<i>p</i> < 0.05). Meanwhile, patients in the Exp group experienced a greatly lower incidence of complications (IOC), pain scores, and average hospital stays (HS), presenting statistically/significant differences compared to those in the Ctrl group (<i>p</i> < 0.05). The combination of the VSD technique with CNM dressings demonstrated advantages in nursing treatment of LT patients. This approach could enhance rates of FWH, reduce IOC, alleviate postoperative pain, facilitate LFR, and shorten HS. Furthermore, patients in the Exp group expressed higher nursing satisfaction.</p><p><strong>Conclusions: </strong>Results of this work yielded a novel therapeutic option for clinical practice, enhancing treatment outcomes and rehabilitation processes for LT patients.</p>","PeriodicalId":54595,"journal":{"name":"Postepy Dermatologii I Alergologii","volume":"41 1","pages":"128-135"},"PeriodicalIF":1.4,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10962379/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140295364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"B-ultrasound or CT-guided 3D-printing individualized non-coplanar template brachytherapy for the treatment of locally uncontrolled recurrent head and neck squamous cell carcinoma.","authors":"Pengbing Han, Fengju Li, Yanping Zhang, Liying Gao, Guiqiong Zhang, Qing Guo, Yuxia Zhu, Qun Su","doi":"10.5114/ada.2024.136252","DOIUrl":"10.5114/ada.2024.136252","url":null,"abstract":"<p><strong>Introduction: </strong>It is worth to explore a more effective treatment method to minimize the damage for patients during the treatment process.</p><p><strong>Aim: </strong>To explore the method, feasibility and efficacy of B-ultrasound or computed tomography (CT)-guided 3D printing individualized non-coplanar template brachytherapy in the treatment of locally uncontrolled recurrent head and neck squamous cell carcinoma.</p><p><strong>Material and methods: </strong>Ten patients with locally uncontrolled recurrent head and neck squamous cell carcinoma who were treated in our department from August 2021 to February 2023 were collected and treated by 3D printing individualized non-coplanar template brachytherapy under the guidance of B-ultrasound or CT, using the 192Ir high-dose rate afterloading treatment machine of NUCLETRON Technologies GmbH. The radiation source was 192Ir, with a diameter of 0.5 mm, a length of 3.5 mm, a total dose of 10-24 Gy, 5-8 Gy/time, once a week.</p><p><strong>Results: </strong>According to the efficacy evaluation criteria, CT scan was performed after 1-6 months, followed up for 24 months, including CR 40% (4/10), PR 50% (5/10), NC 10% (5/10), PD 0 (0). The total effective rate of CR + PR was 90% (9/10), the 6-month local control rate was 90%, the 12-month local control rate was 80%, the 18-month local control rate was 70%, and the 24-month local control rate was 70%. The overall survival rate at 24 months was 100%.</p><p><strong>Conclusions: </strong>Safe and effective interpolation is used to guide the 3D printing of a single non-coplanar template with B-ultrasound or CT in the radiotherapy of local and uncontrolled recurrent head and neck squamous cell carcinoma. According to the guidance of B-ultrasound or CT, the 3D printing individualized non-coplanar template has an obvious healing effect especially in the brachytherapy, and can also protect the functional organs well, with less side effects and fewer complications. Therefore, this method is the most effective for the treatment of locally uncontrolled recurrent head and neck squamous cell carcinoma.</p>","PeriodicalId":54595,"journal":{"name":"Postepy Dermatologii I Alergologii","volume":"41 1","pages":"41-48"},"PeriodicalIF":1.4,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10962369/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140295349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Clinical relevance of cluster analysis in phenotyping allergic rhinitis in the paediatric population of the Kuyavian-Pomeranian voivodeship, Poland.","authors":"Agnieszka Kowalczyk, Aneta Krogulska","doi":"10.5114/ada.2023.135676","DOIUrl":"10.5114/ada.2023.135676","url":null,"abstract":"<p><strong>Introduction: </strong>Allergic rhinitis (AR) is the most common allergic disease in the world, and additionally, its prevalence is successively increasing. Children with AR constitute a heterogeneous group of patients differing both in the course of AR and in the frequency of asthma coexistence. It is possible to identify children with AR at risk of a more severe course of the disease by analysing the potential family, environmental and clinical factors related to the development of the disease; the findings will help identify patients with a higher risk of developing asthma in the future, and who will benefit the most from early allergen-specific immunotherapy.</p><p><strong>Aim: </strong>Evaluation of clinical relevance of cluster analysis in phenotyping AR based on an analysis of selected clinical and environmental factors.</p><p><strong>Material and methods: </strong>The study sample was 80 children (7-17 y.o.) with AR, including 28 children with associated asthma. The effects of AR symptoms on the patients daily functioning, skin prick tests (Allergopharma), allergen-specific IgE for airborne allergens (Biocheck GmbH), total cholesterol, cholesterol high-density lipoprotein (HDL), cholesterol low-density lipoprotein (LDL), triglyceride levels in the blood (ARCHITECTcSystem), FeNO and nNO concentrations (HypAir FeNO Medisoft) and results of methacholine challenge test (Lungtest 1000Ispa) were analysed.</p><p><strong>Results: </strong>Four clusters of patients with AR were extracted, differing in the incidence and severity of AR symptoms and the coincidence of asthma. Most of the children from cluster 1 (<i>n</i> = 24; 85.71%) and cluster 2 (<i>n</i> = 15; 78.95%) had persistent AR, while most of the children from cluster 3 (<i>n</i> = 11; 73.33%) and cluster 4 (<i>n</i> = 14; 77.78%) had intermittent AR. The co-occurrence of asthma was significantly higher in cluster 1 than in other clusters (<i>p</i> = 0.0002). Children in clusters 3 and 4 reported a lower impact of AR symptoms on daily functioning (<i>p</i> = 0.0153). Children in cluster 1 had significantly more often an abnormally high total cholesterol level (<i>p</i> = 0.033) and in cluster 4 significantly more often abnormally high triglyceride levels (<i>p</i> = 0.009) were observed. Patients in cluster 2 were significantly less likely to have abnormal high LDL levels (<i>p</i> = 0.015).</p><p><strong>Conclusions: </strong>Children with AR from the Kuyavian-Pomeranian voivodeship differing in the course of AR, the frequency of coexistence of asthma, and occurrence of lipid parameter abnormalities.</p>","PeriodicalId":54595,"journal":{"name":"Postepy Dermatologii I Alergologii","volume":"41 1","pages":"56-65"},"PeriodicalIF":1.4,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10962368/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140295350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Michał Niedźwiedź, Marcin Noweta, Joanna Narbutt, Witold Owczarek, Magdalena Ciążyńska, Agnieszka Czerwińska, Janusz Krzyścin, Aleksandra Lesiak, Małgorzata Skibińska
{"title":"Does the effectiveness of biological medications in the treatment for psoriasis depend on the moment of starting therapy? A preliminary study.","authors":"Michał Niedźwiedź, Marcin Noweta, Joanna Narbutt, Witold Owczarek, Magdalena Ciążyńska, Agnieszka Czerwińska, Janusz Krzyścin, Aleksandra Lesiak, Małgorzata Skibińska","doi":"10.5114/ada.2024.135917","DOIUrl":"10.5114/ada.2024.135917","url":null,"abstract":"<p><strong>Introduction: </strong>It is well known that biological medications acting on selected elements of the immune response are highly effective in psoriasis treatment. It is a common perception that psoriasis is a seasonal disorder with improvement in warmer months, however it has not been unequivocally confirmed. It is not known whether the time of year of starting systematic therapy for psoriasis influences treatment outcomes.</p><p><strong>Material and methods: </strong>Changes in psoriasis severity scores during treatment with biologics were investigated. The scores were recorded for 62 patients with moderate to severe psoriasis at the beginning, after 1, 4 and 7 months of the therapy. Patients were divided into two groups: those beginning the treatment in the cold period of the year (November-March) and in the warm period (May-September). The seasonal groups were also divided into subgroups according to the type of biologics used: interleukin inhibitors and tumor necrosis factor α (TNF-α) inhibitors. Results of the treatment were analysed using standard statistical tests of differences between samples.</p><p><strong>Results: </strong>After 1 and 4 months of the therapy, better efficacy of interleukin inhibitors was found in patients starting treatment in summer. The course of psoriasis improvement in patients taking TNF-α inhibitors resulted in consistent improvement regardless of the season. The outcome of the treatment after 7 months was similar for both seasonal groups and types of biologics used.</p><p><strong>Conclusions: </strong>Our understanding of the effectiveness of the treatments depending on the time of the year combined with the type of biologics used, may further improve results of the therapy.</p>","PeriodicalId":54595,"journal":{"name":"Postepy Dermatologii I Alergologii","volume":"41 1","pages":"106-112"},"PeriodicalIF":1.4,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10962378/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140295356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vanesa García-Paz, Carolina Gómez-Farińas, Soledad Sánchez-Sánchez, Andrea Otero-Alonso, Clara Carballas-Vázquez, Leticia Vila-Sexto
{"title":"Linear IgA dermatosis secondary to treatment with piperacillin-tazobactam in a nonagenarian patient.","authors":"Vanesa García-Paz, Carolina Gómez-Farińas, Soledad Sánchez-Sánchez, Andrea Otero-Alonso, Clara Carballas-Vázquez, Leticia Vila-Sexto","doi":"10.5114/ada.2023.133817","DOIUrl":"10.5114/ada.2023.133817","url":null,"abstract":"","PeriodicalId":54595,"journal":{"name":"Postepy Dermatologii I Alergologii","volume":"40 6","pages":"814-816"},"PeriodicalIF":1.4,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10809834/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139571578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Maciej Kupczyk, Wojciech Barg, Grażyna Bochenek, Grzegorz Brożek, Piotr D Browiecki, Dorota Brzostek, Andrzej D Browski, Rafał Dobek, Radosław Gawlik, Aleksandra Kucharczyk, Izabela Kupryś-Lipińska, Agnieszka Mastalerz-Migas, Marek L Kowalski
{"title":"Predictors of excessive short-acting β<sub>2</sub>-agonist use and asthma exacerbations: a retrospective analysis of a Polish prescription database.","authors":"Maciej Kupczyk, Wojciech Barg, Grażyna Bochenek, Grzegorz Brożek, Piotr D Browiecki, Dorota Brzostek, Andrzej D Browski, Rafał Dobek, Radosław Gawlik, Aleksandra Kucharczyk, Izabela Kupryś-Lipińska, Agnieszka Mastalerz-Migas, Marek L Kowalski","doi":"10.5114/ada.2023.133454","DOIUrl":"10.5114/ada.2023.133454","url":null,"abstract":"<p><strong>Introduction: </strong>Despite being linked to unfavourable outcomes, short-acting β<sub>2</sub>-agonists (SABAs) are still overused by a substantial proportion of patients with asthma.</p><p><strong>Aim: </strong>To analyse the prevalence and predictors of SABA overuse and exacerbations in patients with asthma in a nationwide database of prescription purchase records.</p><p><strong>Material and methods: </strong>The prevalence of excessive SABA use (≥ 12 canisters) and overuse (≥ 3 canisters) was analysed among patients aged 18-64 years who purchased asthma medications in 2018. Predictors of excessive SABA use and SABA overuse were examined by quasi-Poisson regression. Negative binomial regression was used to study the association of excessive SABA use or overuse to the risk of asthma exacerbation defined as a prescription for oral corticosteroids.</p><p><strong>Results: </strong>Of 91,763 patients with asthma, 42,189 (46%) were SABA users (mean age, 47 years; 58% female). Among them, 34% purchased ≥ 3 SABA canisters, and 6% purchased ≥ 12 canisters. The risk (risk ratio, 95% CI) of excessive SABA use was lower in patients with concomitant prescriptions for inhaled corticosteroids (0.41, 0.34-0.48) or inhaled corticosteroids and long-acting β<sub>2</sub>-agonists (0.52, 0.47-0.56), women (0.63, 0.58-0.68), and those in secondary care (0.60, 0.44-0.66); older age was associated with a higher risk of excessive SABA use (1.06, 1.03-1.10). Excessive SABA use was the strongest predictor of asthma exacerbations among all patients (3.24, 2.84-3.70) and in those with ≥ 1 exacerbation (1.60, 1.50-1.71).</p><p><strong>Conclusions: </strong>Excessive SABA use is highly prevalent in asthma management, is associated with lack of prescriptions for inhaled corticosteroids, and substantially increases the exacerbation risk.</p>","PeriodicalId":54595,"journal":{"name":"Postepy Dermatologii I Alergologii","volume":"40 6","pages":"790-797"},"PeriodicalIF":1.4,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10809829/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139571649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}